Applied and Environmental Microbiology · 2022 · 10 citations · 29 references
Life SciencesBiotechnologyMicrobiologyDrug DiscoveryEnzymologyMicrobial PathogenesisBacterial PathogenesisBacterial Secretion SystemsBacterial ToxinsBacterial Virulence FactorsMicrobial Virulence FactorsPathogen Virulence FactorsAntibiotic DiscoveryAntimicrobial Drug DevelopmentBacterial Toxin ProductionBacterial Virulence GenesMicrobial Genome-encoded BiosynthesisNovel Antibacterial Drug DiscoveryType Iii Secretion System Effectors
Enterohemorrhagic Escherichia coli (EHEC) is a significant global pathogen for which traditional antibiotic treatment is not recommended. Aurodox inhibits the ability of EHEC to establish infection in the host gut through the specific targeting of the type III secretion system while circumventing the induction of toxin production associated with traditional antibiotics. These properties suggest aurodox could be a promising anti-virulence compound for EHEC, which merits further investigation. Here, we characterized the aurodox biosynthetic gene cluster from Streptomyces goldiniensis and established the key enzymatic steps of aurodox biosynthesis that give rise to the unique anti-virulence activity. These data provide the basis for future chemical and genetic approaches to produce aurodox derivatives with increased efficacy and the potential to engineer novel elfamycins.
29
Prokka: rapid prokaryotic genome annotation
Torsten Seemann · Bioinformatics · 2014 · 19.6K citations
QUAST: quality assessment tool for genome assemblies
Alexey Gurevich, Vladislav Saveliev, Nikolay Vyahhi et al. · Bioinformatics · 2013 · 11.5K citations · Full text
antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline
Kai Blin, Simon J. Shaw, Kat Steinke et al. · Nucleic Acids Research · 2019 · 3.1K citations · Full text
Bertolt Gust, Gregory L. Challis, Kay Fowler et al. · Proceedings of the National Academy of Sciences · 2003 · 1.4K citations